Zimmer Biomet HoldingsXSWX:ZBH +0.68%69 Current Ratio is 1.73 as of Mar. 2026, which is 8% below its 10-year median of 1.88. GuruFocus rates XSWX:ZBH with a GF Score™ of 69/100 and a GF Value™ of CHF100.92 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Zimmer Biomet Holdings ranks worse than 68.54% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Zimmer Biomet Holdings's current ratio for the quarter that ended in Mar. 2026 was 1.73.
Zimmer Biomet Holdings has a current ratio of 1.73. It generally indicates good short-term financial strength.
The historical rank and industry rank for Zimmer Biomet Holdings's Current Ratio or its related term are showing as below:
XSWX:ZBH'
s Current Ratio Range Over the Past 10 Years
Min: 1.17 Med: 1.88 Max: 2.44
Current: 1.73
During the past 13 years, Zimmer Biomet Holdings's highest Current Ratio was 2.44. The lowest was 1.17. And the median was 1.88.
XSWX:ZBH's Current Ratio is ranked worse than 68.54% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 2.48
vs XSWX:ZBH: 1.73
Zimmer Biomet Holdings (XSWX:ZBH) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Zimmer Biomet Holdings Current Ratio Related Terms
Zimmer Biomet Holdings Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:ZBH vs PEN, GMED, STE: Current Ratio Comparison
For the Medical Devices subindustry, Zimmer Biomet Holdings's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zimmer Biomet Holdings Current Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's Current Ratio distribution charts can be found below:
* The bar in red indicates where Zimmer Biomet Holdings's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zimmer Biomet Holdings (XSWX:ZBH) has a Current Ratio of 1.73 as of Mar. 2026. This is near median its historical median of 1.88. Over the past decade, Zimmer Biomet Holdings' Current Ratio has ranged from 1.17 to 2.44. According to the industry distribution chart, Zimmer Biomet Holdings ranks #586 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 68.5%.
Is Zimmer Biomet Holdings' Current Ratio too high?
Zimmer Biomet Holdings' current Current Ratio of 1.73 is near median its 10-year median of 1.88. Over the past 10 years, this metric has ranged from a low of 1.17 to a high of 2.44. The Medical Devices & Instruments industry median Current Ratio is 2.48. Zimmer Biomet Holdings' value of 1.73 is 30.2% below this industry median. Based on the distribution chart, Zimmer Biomet Holdings ranks #586 out of 855 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Zimmer Biomet Holdings has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zimmer Biomet Holdings' Current Ratio compare to PEN and GMED?
According to the Medical Devices & Instruments industry distribution chart, Zimmer Biomet Holdings ranks #586 out of 855 companies for Current Ratio. This places Zimmer Biomet Holdings in the lower half of its industry. The industry median Current Ratio is 2.48. Zimmer Biomet Holdings' value of 1.73 is 30.2% below this benchmark. Historically, Zimmer Biomet Holdings' own Current Ratio has ranged from 1.17 to 2.44 over the past decade. While the company's 10-year median is 1.88 vs. the industry median of 2.48, Zimmer Biomet Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.48, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zimmer Biomet Holdings's current Current Ratio of 1.73 is 30.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zimmer Biomet Holdings's current Current Ratio is 1.73, which is near median its own 10-year median of 1.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zimmer Biomet Holdings stock overvalued right now?
Based on GuruFocus' analysis, Zimmer Biomet Holdings (XSWX:ZBH) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF100.92, compared to a current price of CHF74.50 — trading 26.2% below its estimated fair value. The current Current Ratio is 1.73, which is near median its 10-year median of 1.88 and 30.2% below the Medical Devices & Instruments industry median of 2.48. Zimmer Biomet Holdings' overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Zimmer Biomet Holdings (XSWX:ZBH), the current Current Ratio is 1.73 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zimmer Biomet Holdings (XSWX:ZBH) Overvalued in 2026?
Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued.
The current stock price of CHF74.50 is trading 26.2% below its estimated GF Value™ of CHF100.92.
GuruFocus considers Zimmer Biomet Holdings to be Modestly Undervalued.
Key valuation signals for XSWX:ZBH:
Current Ratio: 1.73 (near median its 10-year median of 1.88)
GF Value™: CHF100.92 vs. price of CHF74.50 (26.2% below fair value)
Industry Position: 30.2% below the Medical Devices & Instruments median (#586 of 855)
No single metric tells the full story. See the XSWX:ZBH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
69GF Score
Get the complete analysis for XSWX:ZBH
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:ZBH has been successfully added to your 
